TAFI gene polymorphisms in patients with cerebral venous thrombosis

dc.authoridZamani, Ayse Gul/0000-0003-0329-9047
dc.contributor.authorTokgoz, Serhat
dc.contributor.authorZamani, Ayse Gul
dc.contributor.authorDurakbasi-Dursun, Hatice Gul
dc.contributor.authorYilmaz, Osman
dc.contributor.authorIlhan, Nurhan
dc.contributor.authorDemirel, Sennur
dc.contributor.authorTavli, Mithat
dc.date.accessioned2025-03-23T19:42:17Z
dc.date.available2025-03-23T19:42:17Z
dc.date.issued2013
dc.departmentSinop Üniversitesi
dc.description.abstractGene polymorphisms of thrombin activatable fibrinolysis inhibition (TAFI) factor have been investigated in various studies in terms of etiology (recurrence) and treatment (fibrinolytic effect) of thrombus formation. Cerebral venous thrombosis (CVT) is a life-threatening disease observed in young persons. Fifty-nine patients with CVT and 100 healthy control subjects were enrolled in the case/control study. The association between TAFI gene polymorphisms -438G > A, +505A > G and +1040C > T and cerebral venous thrombosis was investigated. It was found that frequencies of polymorphic genotype and allele were not different in patients than in control group and that they were not significant for cerebral venous thrombosis.
dc.identifier.doi10.1007/s13760-012-0170-6
dc.identifier.endpage297
dc.identifier.issn0300-9009
dc.identifier.issue3
dc.identifier.pmid23264082
dc.identifier.scopus2-s2.0-84883428584
dc.identifier.scopusqualityQ2
dc.identifier.startpage291
dc.identifier.urihttps://doi.org/10.1007/s13760-012-0170-6
dc.identifier.urihttps://hdl.handle.net/11486/6754
dc.identifier.volume113
dc.identifier.wosWOS:000323729100013
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer Heidelberg
dc.relation.ispartofActa Neurologica Belgica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250323
dc.subjectTAFI
dc.subjectCerebral venous thrombosis
dc.subject438G > A
dc.subject505A > G
dc.subject1040C > T
dc.subjectSinus thrombosis
dc.titleTAFI gene polymorphisms in patients with cerebral venous thrombosis
dc.typeArticle

Dosyalar